Bradley Foster & Sargent’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.39M Sell
84,197
-12,481
-13% -$820K 0.08% 156
2026
Q1
$6.88M Sell
96,678
-1,147
-1% -$90.4K 0.11% 133
2025
Q4
$8.02M Sell
97,825
-6,240
-6% -$486K 0.12% 136
2025
Q3
$7.82M Sell
104,065
-30,582
-23% -$2.28M 0.12% 131
2025
Q2
$9.97M Sell
134,647
-100,433
-43% -$6.99M 0.16% 110
2025
Q1
$19M Sell
235,080
-11,075
-4% -$952K 0.32% 76
2024
Q4
$19.2M Sell
246,155
-159,032
-39% -$13.5M 0.32% 75
2024
Q3
$38M Buy
405,187
+12,599
+3% +$1.06M 0.64% 47
2024
Q2
$30.6M Buy
392,588
+185,552
+90% +$15.1M 0.55% 50
2024
Q1
$18.8M Buy
207,036
+201,162
+3,425% +$16.7M 0.34% 68
2023
Q4
$454K Sell
5,874
-3,334
-36% -$233K 0.01% 356
2023
Q3
$748K Hold
9,208
0.02% 295
2023
Q2
$748K Buy
9,208
+583
+7% +$46.5K 0.02% 295
2023
Q1
$707K Buy
+8,625
New +$616K 0.02% 285

Other funds holding GEHC

Bradley Foster & Sargent's GEHC Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its GE HealthCare (GEHC) stake by 13% in Q2 2026, selling an estimated $820K and leaving 84,197 shares worth $5.39M. The position accounts for 0.08% of the portfolio, ranked #156.

Bradley Foster & Sargent first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $38M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bradley Foster & Sargent held 84,197 shares of GE HealthCare worth $5.39M as of Q2 2026.
  • Bradley Foster & Sargent sold 12,481 GE HealthCare shares in Q2 2026, an estimated $820K.
  • GE HealthCare made up 0.08% of Bradley Foster & Sargent's portfolio in Q2 2026, its #156 holding.
  • Bradley Foster & Sargent first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bradley Foster & Sargent's GE HealthCare position peaked at $38M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.